Official Title
SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
Brief Summary

The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.

Detailed Description

BioSafety Technologies has developed a rapid detection test to clear people of COVID-19.

A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear
(Negative) or Infected (Positive). The user-friendly process does not involve medically
trained personnel.

The study will compare TeraSystem test results against PCR test results. Persons
participating will be persons having a PCR test as part of the Health System and consenting
to participate.

Withdrawn
COVID19

Diagnostic Test: Breath sample

Patient will blow into a tube 5 times.

Eligibility Criteria

Inclusion Criteria:

Older than 7 years odf age Able to provide informed consent Able to take the breath test

Exclusion Criteria:

Younger than 7 years of age Unable to provide informed consent Unable to take the breath
test

Eligibility Gender
All
Eligibility Age
Minimum: 7 Years ~ Maximum: N/A
Countries
Costa Rica
Locations

Instituto Costarricense de Investigaciones Clínicas
San José, Costa Rica

Guillermo Rodríguez Gómez, MD, Principal Investigator
Founder and Investigator

Instituto Costarricense de Investigaciones Clínicas ICIC
NCT Number
Keywords
SARS-CoV-2, coronavirus testing
MeSH Terms
COVID-19